Literature DB >> 28616718

Effect of Intrastriatal 6-OHDA Lesions on Extrastriatal Brain Structures in the Mouse.

Birte Becker1, Melek Demirbas2, Sonja Johann2, Adib Zendedel2,3, Cordian Beyer2, Hans Clusmann4, Stefan Jean-Pierre Haas5, Andreas Wree5, Sonny Kian Hwie Tan4, Markus Kipp6.   

Abstract

Parkinson's disease (PD) is a neurodegenerative disorder characterized by progressive loss of midbrain dopaminergic neurons, resulting in motor and non-motor symptoms. The underlying pathology of non-motor symptoms is poorly understood. Discussed are pathological changes of extrastriatal brain structures. In this study, we characterized histopathological alterations of extrastriatal brain structures in the 6-hydroxydopamine (6-OHDA) PD animal model. Lesions were induced by unilateral stereotactic injections of 6-OHDA into the striatum or medial forebrain bundle of adult male mice. Loss of tyrosine hydroxylase positive (TH+) fibers as well as glia activation was quantified following stereological principles. Loss of dopaminergic innervation was further investigated by western-blotting. As expected, 6-OHDA injection into the nigrostriatal route induced retrograde degeneration of dopaminergic neurons within the substantia nigra pars compacta (SNpc), less so within the ventral tegmental area. Furthermore, we observed a region-specific drop of TH+ projection fiber density in distinct cortical regions. This pathology was most pronounced in the cingulate- and motor cortex, whereas the piriform cortex was just modestly affected. Loss of cortical TH+ fibers was not paralleled by microglia or astrocyte activation. Our results demonstrate that the loss of dopaminergic neurons within the substantia nigra pars compacta is paralleled by a cortical dopaminergic denervation in the 6-OHDA model. This model serves as a valuable tool to investigate mechanisms operant during cortical pathology in PD patients. Further studies are needed to understand why cortical dopaminergic innervation is lost in this model, and what functional consequence is associated with the observed denervation.

Entities:  

Keywords:  6-OHDA; Cerebral cortex; Mouse; Nigrostriatal lesion; Parkinson’s disease; Tyrosine hydroxylase

Mesh:

Substances:

Year:  2017        PMID: 28616718     DOI: 10.1007/s12035-017-0637-9

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  10 in total

1.  Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.

Authors:  Stefan Esser; Larissa Göpfrich; Kai Bihler; Eugenia Kress; Stella Nyamoya; Simone C Tauber; Tim Clarner; Matthias B Stope; Thomas Pufe; Markus Kipp; Lars-Ove Brandenburg
Journal:  Mol Neurobiol       Date:  2017-12-29       Impact factor: 5.590

2.  Different Methods for Evaluating Microglial Activation Using Anti-Ionized Calcium-Binding Adaptor Protein-1 Immunohistochemistry in the Cuprizone Model.

Authors:  Mariela Wittekindt; Hannes Kaddatz; Sarah Joost; Anna Staffeld; Yamen Bitar; Markus Kipp; Linda Frintrop
Journal:  Cells       Date:  2022-05-24       Impact factor: 7.666

3.  Neurotoxin-Induced Animal Models of Parkinson Disease: Pathogenic Mechanism and Assessment.

Authors:  Xian-Si Zeng; Wen-Shuo Geng; Jin-Jing Jia
Journal:  ASN Neuro       Date:  2018 Jan-Dec       Impact factor: 4.146

4.  Triglyceride Form of Docosahexaenoic Acid Mediates Neuroprotection in Experimental Parkinsonism.

Authors:  Maricel Gómez-Soler; Begoña Cordobilla; Xavier Morató; Víctor Fernández-Dueñas; Joan C Domingo; Francisco Ciruela
Journal:  Front Neurosci       Date:  2018-08-28       Impact factor: 4.677

Review 5.  Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease.

Authors:  Jelena Osmanovic Barilar; Ana Knezovic; Ana Babic Perhoc; Jan Homolak; Peter Riederer; Melita Salkovic-Petrisic
Journal:  J Neural Transm (Vienna)       Date:  2020-02-06       Impact factor: 3.575

6.  P2X4R Overexpression Upregulates Interleukin-6 and Exacerbates 6-OHDA-Induced Dopaminergic Degeneration in a Rat Model of PD.

Authors:  Jiangnan Ma; Jinzhao Gao; Mengyue Niu; Xiaona Zhang; Jing Wang; Anmu Xie
Journal:  Front Aging Neurosci       Date:  2020-11-04       Impact factor: 5.750

7.  CB2 Agonist GW842166x Protected against 6-OHDA-Induced Anxiogenic- and Depressive-Related Behaviors in Mice.

Authors:  Xiaojie Liu; Hao Yu; Bixuan Chen; Vladislav Friedman; Lianwei Mu; Thomas J Kelly; Gonzalo Ruiz-Pérez; Li Zhao; Xiaowen Bai; Cecilia J Hillard; Qing-Song Liu
Journal:  Biomedicines       Date:  2022-07-22

8.  Inhibition of formyl peptide receptors improves the outcome in a mouse model of Alzheimer disease.

Authors:  Nicole Schröder; Anja Schaffrath; Josua A Welter; Tim Putzka; Angelika Griep; Patrick Ziegler; Elisa Brandt; Sebastian Samer; Michael T Heneka; Hannes Kaddatz; Jiangshan Zhan; Eugenia Kipp; Thomas Pufe; Simone C Tauber; Markus Kipp; Lars-Ove Brandenburg
Journal:  J Neuroinflammation       Date:  2020-04-24       Impact factor: 8.322

9.  Motor Cortex Stimulation Reversed Hypernociception, Increased Serotonin in Raphe Neurons, and Caused Inhibition of Spinal Astrocytes in a Parkinson's Disease Rat Model.

Authors:  Ana Carolina P Campos; Miriã B Berzuíno; Gabriela R Barbosa; Helena M R C Freire; Patricia S Lopes; Danielle V Assis; Erich T Fonoff; Rosana L Pagano
Journal:  Cells       Date:  2021-05-11       Impact factor: 6.600

10.  Long-Term Glucose Starvation Induces Inflammatory Responses and Phenotype Switch in Primary Cortical Rat Astrocytes.

Authors:  Cordian Beyer; Jochen Seitz; Vanessa Kogel; Stefanie Trinh; Natalie Gasterich
Journal:  J Mol Neurosci       Date:  2021-02-12       Impact factor: 3.444

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.